Colorectal Cancer Prevention
Colorectal Cancer Prevention
Colorectal cancer is one of the few cancers where screening does not merely find the disease earlier — it prevents it, by removing the polyp before it turns malignant. That makes the schedule worth getting right.
Screening: the test that prevents as well as detects
In most cancers, screening finds disease earlier. In colorectal cancer it also prevents disease, because the polyp that would have become a cancer can be removed during the examination that finds it. This is why the screening schedule in this disease is not a matter of preference.
Average risk
Begin colonoscopy at around age 45 and repeat on the interval dictated by the findings — commonly ten years where nothing is found, shorter where polyps are removed. In China these examinations are also available through organised programmes covering defined age groups.
Stool-based alternatives
Faecal immunochemical testing detects invisible blood and is repeated annually; stool DNA testing adds molecular markers. Both are legitimate choices where colonoscopy is not acceptable, with the essential caveat that a positive result requires colonoscopy to complete the assessment. A negative stool test does not exclude a polyp.
When symptoms come first
A symptom is investigated on its own timetable, not on the screening schedule. Bleeding, a persistent change in bowel habit or unexplained anaemia are assessed at the time they appear, regardless of when the last screening examination took place.
Polyps: what removal does and does not achieve
Removing an adenoma interrupts the pathway to cancer, and this is the mechanism by which screening reduces both incidence and deaths. Two points are worth being precise about, because both are frequently misunderstood.
What removal achieves
Removing an advanced adenoma substantially reduces the risk of subsequently developing colorectal cancer. Removal is not a treatment for a cancer that is already invasive, however — once a lesion has grown into the wall, it requires staging and a proper operation rather than an endoscopic removal.
What removal does not achieve
Removing a polyp does not return risk to that of someone who never had one. New polyps can form, and a proportion of patients develop them again. This is why surveillance continues on a defined schedule after polyps have been removed, and why a normal examination at one point is not a permanent result.
Surveillance intervals after polypectomy follow guideline categories based on number, size and histology; the previous report should be obtained rather than summarised.
Working out which schedule applies to you
Guidelines organise screening by risk group, so the practical first step is establishing which group you are in. That takes a structured conversation rather than a general recommendation.
- Family history — who was affected, at what age, on which side of the family, and whether there were endometrial, ovarian or urinary tract cancers
- Previous colonoscopy reports — the number, size and type of any polyps removed, and the interval that was recommended at the time
- Any genetic test results — yours, or those of an affected relative if they are available
- Bowel disease — the type, the extent of colonic involvement and the number of years since diagnosis
- Previous radiotherapy to the abdomen or pelvis, and the age at which it was given
Surveillance for higher-risk groups
Begin screening around age 40, or ten years before the youngest affected relative was diagnosed, whichever is earlier, and repeat at a shortened interval set individually.
Colonoscopy from a young age at one- to two-year intervals, together with surveillance for the other cancers the syndrome predisposes to. Because the pattern is inherited dominantly, genetic counselling and testing are offered to relatives.
Endoscopy from adolescence, with the timing of surgery to remove the colon determined by the polyp burden. Family members are offered genetic testing so that carriers begin surveillance and non-carriers are spared it.
Surveillance colonoscopy begins after a defined number of years of disease depending on how much of the colon is involved, and continues at intervals influenced by inflammation control, previous dysplasia and associated liver disease.
Lifestyle measures and how much they change
The modifiable factors are limited and their effects are modest compared with age and inherited risk. Diet does not substitute for screening in this disease — a point worth stating plainly, because the two are often discussed as alternatives.
Diet
High intake of red and processed meat is associated with increased risk; diets rich in fibre, vegetables and fruit are associated with lower risk. The direction is consistent and the effect size is modest.
Alcohol and smoking
Both raise risk, and smoking also worsens outcomes after a diagnosis. Reducing or stopping remains worthwhile at any age.
Weight and activity
Higher body weight and inactivity are associated with increased risk, and regular moderate activity with lower risk. Aspirin and similar agents reduce risk in selected individuals but carry their own risks and are a clinical decision rather than a general measure.
What screening can and cannot do
What it does well
It removes the precursor lesion, so it prevents a proportion of cancers outright. It finds tumours earlier, when surgery alone is often sufficient, and it detects synchronous lesions elsewhere in the bowel that would otherwise be discovered later.
Where it falls short
Some polyps are flat and easily missed, particularly sessile serrated lesions. Some cancers grow quickly between examinations. Colonoscopy is not risk-free, and the quality of the bowel preparation materially affects what can be seen. A negative examination reduces risk; it does not eliminate it.
Symptoms override a previous result
Bleeding, a new change in bowel habit or unexplained anaemia needs assessment even if a recent examination was normal. Screening intervals are set for people without symptoms; symptoms follow the diagnostic pathway instead.
Preparation quality matters
An incomplete or poorly prepared examination may need to be repeated sooner, and the report should state whether the caecum was reached and how good the preparation was. A report that does not state this leaves the interval undetermined.
Building your own plan
Family history, personal polyp history, genetic results if any, bowel disease and previous radiotherapy. Done once and revisited when something changes.
Colonoscopy for most; stool-based testing only where colonoscopy is not acceptable, with the understanding that a positive result leads to colonoscopy. The interval follows from what was found, not from convenience.
The number, size and type of polyps removed determines the next interval, and the earlier report is the only record of it. Ask for a copy of the endoscopy and pathology reports each time.
Confirm in advance where a suspicious finding would be assessed and by whom. Prompt referral should be a property of the plan rather than a matter of luck.
For patients who have already been treated for colorectal cancer, surveillance has an additional purpose — detecting recurrence — and a different schedule, including regular CEA measurement where it was raised at diagnosis. That is covered in the practical questions page. The risk factors behind these recommendations are set out in causes and risk factors.